Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02033694 · ClinicalTrials.gov registry record

The Lipid-Rich Plaque Study

A clinical trial, sponsored by Infraredx.

Completed
Registry status
1,563
Enrollment target

NCT02033694: Completed study, sponsored by Infraredx.

NCT02033694 is a clinical trial that has completed, run by Infraredx. The registered enrollment target is 1,563 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02033694 has completed, sponsored by Infraredx.

COMPLETED
Registry status
1,563 participants
Enrollment target

Study Summary

The purpose of this study is to enhance medical knowledge of the causes of future coronary problems. Many studies in patients who have already experienced a coronary problem point to the danger associated with plaques that are rich in cholesterol. This study determines if the near-infrared method of detection of these fatty plaques can predict future events. If dangerous plaques can be identified, there are many treatments already available that could be tested for their ability to prevent coronary events.

Primary Outcome

Association of maximum 4 mm Lipid Core Burden Index (maxLCBI4mm) as a continuous value in 100 unit increments in all imaged arteries and NC-MACE at both (1) Patient Level and (2) Plaque Level Non-Index Culprit Lesion related Major Adverse Cardiac Events (NC-MACE) is defined as a composite of: * cardiac death * cardiac arrest * non-fatal myocardial infarction (MI) * acute coronary syndrome * revascularization by coronary artery bypass graft (CABG) or percutaneous intervention (PCI) * rehospital

Interventions

  • DEVICE NIRS-IVUS Imaging (TVC Imaging System)

Trial Details

FieldValue
Enrollment Target 1,563 participants
Start Date 2014-02
Est. Completion 2018-09
Infraredx

6 total trials

What the finished NCT02033694 record still lists

NCT02033694 is an observational study that tracks outcomes without assigning an intervention. Its 1,563 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 1 intervention - of which NIRS-IVUS Imaging (TVC Imaging System) is the first listed.

NCT02033694 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02033694 about?

NCT02033694 is a clinical study titled "The Lipid-Rich Plaque Study". The purpose of this study is to enhance medical knowledge of the causes of future coronary problems. Many studies in patients who have already experienced a coronary problem point to the danger associated with plaques that are rich in cholesterol. This study determines if the near-infrared method of...

What is the current status of trial NCT02033694?

This trial is currently completed. The enrollment target is 1,563 participants. The study started on 2014-02. Estimated completion is 2018-09.

What interventions are being tested in trial NCT02033694?

The interventions under investigation include: NIRS-IVUS Imaging (TVC Imaging System) (DEVICE).

Who is sponsoring clinical trial NCT02033694?

This trial is sponsored by Infraredx, which has 6 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06034080 · 1,566 participants · NA

    Interventions to De-implement Unnecessary Antibiotic Prescribing for Children With Ear Infections

  • NCT06881069 · 1,560 participants · NA

    Reach Through Equitable Implementation in Utah

  • NCT06445946 · 1,572 participants · Phase 4

    DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes

  • NCT02650622 · 1,550 participants

    Genetic and Metabolic Disease in Children

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02033694, the US trial registry maintained by the National Library of Medicine. NCT02033694 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.